PRAXPraxis Precision Medicines,...

Nasdaq praxismedicines.com


$ 48.66 $ -1.43 (-2.85 %)    

Friday, 10-May-2024 15:59:53 EDT
QQQ $ 441.71 $ -1.21 (-0.27 %)
DIA $ 395.04 $ 1.04 (0.26 %)
SPY $ 520.76 $ 0.59 (0.11 %)
TLT $ 90.14 $ -0.49 (-0.54 %)
GLD $ 218.73 $ 1.78 (0.82 %)
$ 48.78
$ 51.24
$ 0.00 x 0
$ 0.00 x 0
$ 48.63 - $ 51.24
$ 12.45 - $ 67.21
124,399
na
330.31M
$ -0.01
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-05-2024 12-31-2023 10-K
2 11-07-2023 09-30-2023 10-Q
3 08-09-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 02-07-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
7 08-08-2022 06-30-2022 10-Q
8 05-09-2022 03-31-2022 10-Q
9 02-28-2022 12-31-2021 10-K
10 11-03-2021 09-30-2021 10-Q
11 08-16-2021 06-30-2021 10-Q
12 05-11-2021 03-31-2021 10-Q
13 03-17-2021 12-31-2020 10-K
14 11-23-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 baird-initiates-coverage-on-praxis-precision-medicine-with-outperform-rating-announces-price-target-of-117

Baird analyst Joel Beatty initiates coverage on Praxis Precision Medicine (NASDAQ:PRAX) with a Outperform rating and announc...

 hc-wainwright--co-reiterates-buy-on-praxis-precision-medicine-maintains-105-price-target

HC Wainwright & Co. analyst Douglas Tsao reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $10...

 praxis-precision-medicines-priced-200m-offering-of-33m-shares-at-5650share

Praxis Precision Medicines, Inc. (NASDAQ:PRAX), a clinical-stage biopharmaceutical company translating genetic insights into th...

 why-westport-fuel-systems-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected ...

 jefferies-maintains-buy-on-praxis-precision-medicine-raises-price-target-to-128

Jefferies analyst Kambiz Yazdi maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from...

 why-praxis-precision-medicines-stock-is-trading-higher-tuesday

Praxis Precision Medicines updates Phase 2a study on PRAX-628 in epilepsy patients with photo paroxysmal response, indicating p...

 hc-wainwright--co-reiterates-buy-on-praxis-precision-medicine-maintains-105-price-target

HC Wainwright & Co. analyst Douglas Tsao reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $10...

 tesla-krispy-kreme-mccormick-and-other-big-stocks-moving-higher-on-tuesday

U.S. stocks were higher, with the Dow Jones index gaining around 50 points on Tuesday.

 praxis-precision-medicines-reports-results-of-prax-628-study-evaluating-photo-paroxysmal-response-ppr-achieving-100-response-in-treated-patients

 Praxis Precision Medicines, Inc. (NASDAQ:PRAX), a clinical-stage biopharmaceutical company translating genetic insights into t...

 hc-wainwright--co-reiterates-buy-on-praxis-precision-medicine-maintains-105-price-target

HC Wainwright & Co. analyst Douglas Tsao reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $10...

 praxis-precision-medicines-files-for-mixed-shelf-offering-of-up-to-750m

-SEC Filing

 praxis-precision-medicine-q4-eps-297-beats-313-estimate-sales-51500k-beat-5000k-estimate

Praxis Precision Medicine (NASDAQ:PRAX) reported quarterly losses of $(2.97) per share which beat the analyst consensus estimat...

 jim-cramer-this-healthcare-stock-is-too-risky-but-shares-jumped-64-over-past-month

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Praxis Precision Medicines, Inc. (NASDAQ: PRAX) is "too r...

 wedbush-maintains-neutral-on-praxis-precision-medicine-raises-price-target-to-29

Wedbush analyst Laura Chico maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Neutral and raises the price target fro...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION